Back

CSF1R regulates monocyte subset differentiation and intracellular metabolism.

Gallerand, A.; Merlin, J.; Caillot, Z.; Delaby, C.; Bord, E.; Han, J.; Dolfi, B.; Castiglione, A.; Grenet, S.; Franceschini, M.; Jarretou, G.; Zair, F. N.; Bore, E.; Tuffin, F.; Dombrowicz, D.; Guinamard, R. R.; Randolph, G. J.; Bertola, A.; Auberger, P.; Jacquel, A.; Hume, D. A.; Williams, J. W.; Bajenoff, M.; Neels, J. G.; Ivanov, S.

2025-07-21 immunology
10.1101/2025.07.17.665275 bioRxiv
Show abstract

Monocytes are key circulating effectors of vascular homeostasis, innate immunity and inflammation. Following their generation in mouse bone marrow, classical (Ly6Chigh) monocytes are mobilized into the blood circulation where they mature into non-classical (Ly6Clow) patrolling monocytes or are recruited into peripheral tissues where they differentiate into tissue resident or inflammatory macrophages. Monocytes and macrophages express CSF1R (CD115), the receptor for lineage-specific growth factors CSF1 and IL34. Here, we report that acute CSF1R blockade or genetic deletion negatively interferes with monocyte intracellular metabolism and reduces blood Ly6Clow monocytes in part by blunting differentiation of Ly6Chigh monocytes. Based upon lineage-specific deletion of GFPT1 (Glutamine-Fructose-6-Phosphate Transaminase 1), the hexosamine biosynthetic pathway (HBP) is identified as a novel regulator of CSF1R expression and monocyte subset diversity. Our findings provide new insights into the link between CSF1R signaling, metabolic regulation, and monocyte survival and differentiation.

Published in Nature Communications (predicted rank #2) · training set

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.